Medspace Sees FY24 Revenue $2.090B-$2.130B Vs $2.138B Est; Sees GAAP EPS $11.71-$12.09 Vs $11.56 Est
Portfolio Pulse from Benzinga Newsdesk
Medspace has revised its FY24 revenue guidance to $2.090B-$2.130B, which is below the previous estimate of $2.138B. However, the company expects its GAAP EPS to be between $11.71 and $12.09, surpassing the earlier estimate of $11.56.
October 21, 2024 | 8:27 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Medspace's updated FY24 guidance shows a slight decrease in expected revenue but an increase in GAAP EPS. This mixed guidance could lead to varied investor reactions.
The decrease in revenue guidance might concern investors, but the higher-than-expected EPS could offset some of these worries. The mixed nature of the guidance suggests a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100